MedTrace Logo

Clinical Outcomes and Biomarkers in Patients With Stage 0-IV Melanoma in Real Clinical Practice

NCT05402059 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1570

Last updated 2022-06-15

No results posted yet for this study

Summary

Prospective non-interventional study of clinical outcomes and biomarkers in patients with stage 0-IV skin melanoma in real clinical practice

Conditions

  • Melanoma
  • Melanoma (Skin)
  • Melanoma, Uveal
  • Melanoma Stage IV
  • Melanoma Stage III
  • Melanoma, Stage II
  • Melanoma in Situ
  • Melanoma, Ocular

Interventions

DRUG

surgery (any volume) and / or pharmaceuticals treatment initiated or planned or only dynamic observation, in accordance with current clinical guidelines

Any kind of treatment or observation (no treatment) initiated or planned in accordance with current clinical practice

Sponsors & Collaborators

  • MelanomaPRO, Russia

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-02
Primary Completion
2024-04-30
Completion
2025-04-30

Countries

  • Russia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05402059 on ClinicalTrials.gov